Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
The companies will share development and commercialization costs as well as potential future profits from the new drugs, they said.
Connecting Global Economies
The companies will share development and commercialization costs as well as potential future profits from the new drugs, they said.